肝硬度异质性对非酒精性脂肪性肝病患者纤维化分期的影响
本研究回顾性分析155例非酒精性脂肪性肝病患者(训练队列)及三个肝病中心169例患者(验证队列)的肝活检与3 Tesla磁共振弹性成像数据,评估肝硬度异质性对磁共振弹性成像纤维化分期与活检分期一致性的影响。结果显示,基于磁共振弹性成像的肝硬度测量值异质性与分期不一致相关,验证队列结果与训练队列相似。
要点
- 肝硬度异质性可影响磁共振弹性成像对非酒精性脂肪性肝病纤维化分期的准确性。
- 磁共振弹性成像肝硬度测量值异质性越高,分期与活检不一致的比例越高。
- 验证队列结果与训练队列相似,支持肝硬度异质性与分期不一致的关联。
核心结论
- 基于磁共振弹性成像的肝硬度测量值异质性与活检和磁共振弹性成像纤维化分期之间的不一致相关。
研究设计与样本
- 回顾性评估155例接受肝活检和3 Tesla磁共振弹性成像的非酒精性脂肪性肝病患者,并在三个肝病中心对169例非酒精性脂肪性肝病患者进行回顾性验证研究。
主要发现
- 基于组织病理学和受试者工作特征曲线分析,确定磁共振弹性成像纤维化分期4期的最佳肝硬度测量值阈值为4.43 kPa(AUROC 0.89),分期≥3期的最佳阈值为3.93 kPa(AUROC 0.89)。
- 共有53例肝硬度测量值高于4期阈值,其中30例活检分期<4期。
- 在这30例分期不一致病例中,86.7%的肝硬度测量值变异性被归类为异质性。
- 在磁共振弹性成像肝硬度测量值分期≥3期的分期不一致病例中,88.9%被归类为异质性。
- 验证队列结果与训练队列相似。
关键数值与推荐
- 肝硬度测量值变异性定义为硬度范围除以最大硬度值。
- 根据变异性低于或高于训练队列平均值,将队列分为均匀组或异质性组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Despite that hepatic fibrosis often affects the liver globally, spatial distribution can be heterogeneous. This study aimed to investigate the effect of liver stiffness (LS) heterogeneity on concordance between MR elastography (MRE)-based fibrosis staging and biopsy staging in patients with NAFLD. APPROACH AND RESULTS: We retrospectively evaluated data from 155 NAFLD patients who underwent liver biopsy and 3 Tesla MRE and undertook a retrospective validation study of 169 NAFLD patients at three hepatology centers. Heterogeneity of stiffness was assessed by measuring the range between minimum and maximum MRE-based LS measurement (LSM). Variability of LSM was defined as the stiffness range divided by the maximum stiffness value. The cohort was divided into two groups (homogenous or heterogeneous), according to whether variability was below or above the average for the training cohort. Based on histopathology and receiver operating characteristic (ROC) analysis, optimum LSM thresholds were determined for MRE-based fibrosis staging of stage 4 (4.43, kPa; AUROC, 0.89) and stage ≥3 (3.93, kPa; AUROC, 0.89). In total, 53 had LSM above the threshold for stage 4. Within this group, 30 had a biopsy stage of <4. In 86.7% of these discordant cases, variability of LSM was classified as heterogeneous. In MRE-based LSM stage ≥3, 88.9% of discordant cases were classified as heterogeneous. Results of the validation cohort were similar to those of the training cohort. CONCLUSIONS: Discordance between biopsy- and MRE-based fibrosis staging is associated with heterogeneity in LSM, as depicted with MRE.
引用
- Kawamura N, Imajo K, Kalutkiewicz KJ, et al. Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2022. PMID: 34951726. doi:10.1002/hep.32302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。